MedTrace Logo

NT-proBNP and Troponin I in Dengue Children

NCT04837430 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2023-09-22

No results posted yet for this study

Summary

To discribe concentration of NT-proBNP and Troponin I in Dengue hemorrhagic shock children, in correlation between concentration of NT-proBNP and troponin I with total fluid admission, respiratory support, using inotrope and vasopressor using.

Conditions

  • Dengue Shock Syndrome
  • Children, Only

Sponsors & Collaborators

  • Le Phuoc Truyen

    lead OTHER

Principal Investigators

  • Truyen P. Le, MD · University of Medicine and Pharmacy at Ho Chi Minh City

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-02
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04837430 on ClinicalTrials.gov